Abstract
Arguably one of the greatest medical advancements in the 20th Century was the discovery of insulin. Physiologically, insulin is a potent hypoglycaemic agent, which is vital in order for plasma glucose levels to be maintained within the normal range of 4- 7mmol/L. Various attempts have been made in the production, purification, formulation and methods of delivery of insulin. Despite alternative routes being investigated, these routes have met with limited success. Although the pulmonary route offers potential for the delivery of polypeptide drugs due to its large surface area for insulin absorption, it has low bioavailability. Microencapsulation and nanoencapsulation exhibit potential progress in insulin delivery although delivery is at an early stage. In this Review, we discuss the structure of insulin and the physiological importance in addition to the injectable and non-injectable methods used. The currently available insulin therapies are presented and the clinical importance of such therapies.
Keywords: Insulin structure, injectable, synthetic, analogues, drug delivery.
Current Pharmaceutical Design
Title:Drug Delivery Systems for the Treatment of Diabetes Mellitus: State of the Art
Volume: 19 Issue: 41
Author(s): Gary G. Adams and Stephen E. Harding
Affiliation:
Keywords: Insulin structure, injectable, synthetic, analogues, drug delivery.
Abstract: Arguably one of the greatest medical advancements in the 20th Century was the discovery of insulin. Physiologically, insulin is a potent hypoglycaemic agent, which is vital in order for plasma glucose levels to be maintained within the normal range of 4- 7mmol/L. Various attempts have been made in the production, purification, formulation and methods of delivery of insulin. Despite alternative routes being investigated, these routes have met with limited success. Although the pulmonary route offers potential for the delivery of polypeptide drugs due to its large surface area for insulin absorption, it has low bioavailability. Microencapsulation and nanoencapsulation exhibit potential progress in insulin delivery although delivery is at an early stage. In this Review, we discuss the structure of insulin and the physiological importance in addition to the injectable and non-injectable methods used. The currently available insulin therapies are presented and the clinical importance of such therapies.
Export Options
About this article
Cite this article as:
Adams G. Gary and Harding E. Stephen, Drug Delivery Systems for the Treatment of Diabetes Mellitus: State of the Art, Current Pharmaceutical Design 2013; 19 (41) . https://dx.doi.org/10.2174/13816128113199990367
DOI https://dx.doi.org/10.2174/13816128113199990367 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Homology-Based Design for Selective GSK-3 Peptide Inhibitors: Patent Applications and Type 2 Diabetes Mellitus
Current Signal Transduction Therapy MicroRNAs in Diabetic β Cell Dysfunction and their Role as Biomarkers
Current Signal Transduction Therapy Platelet Turnover in Atherothrombotic Disease
Current Pharmaceutical Design Novel Therapeutic Targets for Management of Type-2 Diabetes Mellitus
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cardiovascular Tests: Use & Limits of Biochemical Markers - Therapeutic Measurements of ADMA Involved in Cardiovascular Disorders
Current Pharmaceutical Design Can Marine Omega 3 Fatty Acids Prevent and/or Treat Metabolic Syndrome?
Current Nutrition & Food Science Beneficial Extracardiac Effects of Cardiovascular Medications
Current Cardiology Reviews Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Current Cancer Drug Targets Biomarkers of Alzheimer's Disease Risk in Peripheral Tissues; Focus on Buccal Cells
Current Alzheimer Research Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19
Current Medicinal Chemistry Association of Risk Factors, Antimicrobial Resistance Trends and Occurrence of blaTEM, bla SHV and blaCTX M in Escherichia coli Causing Bacteremia
Infectious Disorders - Drug Targets Anti-Vascular Endothelial Growth Factor Drug Treatment of Diabetic Macular Edema: The Evolution Continues
Current Diabetes Reviews Anti-diabetic Phenolic Compounds of Black Carrot (Daucus carota Subspecies sativus var. atrorubens Alef.) Inhibit Enzymes of Glucose Metabolism: An in silico and in vitro Validation
Medicinal Chemistry Mitochondrial Involvement in Psychiatric Illness in Adults
Current Psychiatry Reviews Fetal Protein Restriction, Taurine and Islet Plasticity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Sirtuins: Novel Players in Male Reproductive Health
Current Medicinal Chemistry Adherence to Mediterranean Diet Offers an Additive Protection Over the Use of Statin Therapy: Results from the ATTICA Study (2002-2012)
Current Vascular Pharmacology The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular)
Current Medicinal Chemistry Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT): A Prospective-Randomized Study in Middle Aged Men and Women
Current Vascular Pharmacology The Relationship Between Dietary Lipids and Serum Visfatin and Adiponectin Levels in Postmenopausal Women
Endocrine, Metabolic & Immune Disorders - Drug Targets